BP1 transcriptionally activates bcl-2 and inhibits TNFα-induced cell death in MCF7 breast cancer cells
2007

BP1 Protein and Breast Cancer Cell Survival

publication 10 minutes Evidence: moderate

Author Information

Author(s): Holly S Stevenson, Sidney W Fu, Joseph J Pinzone, Jinguen Rheey, Samuel J Simmens, Patricia E Berg

Primary Institution: Center for Cancer Research, National Cancer Institute, National Institutes of Health

Hypothesis

Does elevated BP1 expression in breast cancer cells correlate with increased cell survival?

Conclusion

Increased BP1 expression in breast cancer cells inhibits apoptosis and may contribute to resistance against therapies.

Supporting Evidence

  • BP1 is expressed in 81% of invasive ductal breast carcinomas.
  • Increased BP1 expression correlates with tumor progression.
  • Stable overexpression of BP1 inhibits apoptosis in MCF7 cells treated with TNFα.
  • BP1 directly activates the bcl-2 gene, an antiapoptotic factor.
  • MCF7 cells with BP1 overexpression show increased bcl-2 mRNA and protein levels.

Takeaway

BP1 helps breast cancer cells live longer by stopping them from dying when they should, which might make treatments less effective.

Methodology

MCF7 cells were treated with TNFα and analyzed for cell viability and apoptosis using MTT and Annexin V assays, along with Western blot and PCR techniques.

Potential Biases

Potential bias due to the use of a single cell line and specific experimental conditions.

Limitations

The study primarily focuses on one cell line and may not represent all breast cancer types.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/bcr1766

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication